Preoperative (cancer antigen 125 (CA125) serum level, ascites volume, and tumor size), intraoperative (bleeding volume, duration of operation, and residual tumor), and postoperative (complication rate and surgical satisfaction rate) conditions of the patients were evaluated. The gene discussed is MUC16; the disease is neoplasm.